Jos Janssens
About
In The Last Decade
Jos Janssens
18 papers receiving 332 citations
Peers
Comparison fields: 5 of 61
- Oncology 236
- Surgery 133
- Pulmonary and Respiratory Medicine 77
- Molecular Biology 54
- Hepatology 44
Countries citing papers authored by Jos Janssens
This map shows the geographic impact of Jos Janssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Janssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Janssens more than expected).
Fields of papers citing papers by Jos Janssens
This network shows the impact of papers produced by Jos Janssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Janssens. The network helps show where Jos Janssens may publish in the future.
Co-authorship network of co-authors of Jos Janssens
This figure shows the co-authorship network connecting the top 25 collaborators of Jos Janssens. A scholar is included among the top collaborators of Jos Janssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Janssens. Jos Janssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 10 | |
| 6 | 6 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Response to the local treatment after chemoradiation and surgery as secondary endpoint | 6 |
| 10 | 4 | |
| 11 | 127 | |
| 12 | 18 | |
| 13 | The medical treatment of colorectal cancer: actual status and new developments. | 25 |
| 14 | 1 | |
| 15 | Microsatellite Instability as an Indicator of Hereditary Susceptibility to Colon Cancer | 2 |
| 16 | Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study. | 9 |
| 17 | The three-group metaphase as a morphologic indicator of high-ploidy cells in cervical intraepithelial neoplasia. | 9 |
| 18 | 55 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.